Your browser doesn't support javascript.
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.
Desai, Niyati; Neyaz, Azfar; Szabolcs, Annamaria; Shih, Angela R; Chen, Jonathan H; Thapar, Vishal; Nieman, Linda T; Solovyov, Alexander; Mehta, Arnav; Lieb, David J; Kulkarni, Anupriya S; Jaicks, Christopher; Xu, Katherine H; Raabe, Michael J; Pinto, Christopher J; Juric, Dejan; Chebib, Ivan; Colvin, Robert B; Kim, Arthur Y; Monroe, Robert; Warren, Sarah E; Danaher, Patrick; Reeves, Jason W; Gong, Jingjing; Rueckert, Erroll H; Greenbaum, Benjamin D; Hacohen, Nir; Lagana, Stephen M; Rivera, Miguel N; Sholl, Lynette M; Stone, James R; Ting, David T; Deshpande, Vikram.
  • Desai N; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Neyaz A; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Szabolcs A; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Shih AR; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Chen JH; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Thapar V; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Nieman LT; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Solovyov A; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Mehta A; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Lieb DJ; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Kulkarni AS; The Broad Institute, Cambridge, MA, 02142, USA.
  • Jaicks C; The Broad Institute, Cambridge, MA, 02142, USA.
  • Xu KH; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Raabe MJ; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Pinto CJ; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Juric D; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Chebib I; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Colvin RB; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Kim AY; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Monroe R; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Warren SE; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Danaher P; Advanced Cell Diagnostics, a Bio-Techne Brand, Newark, CA, 94560, USA.
  • Reeves JW; NanoString Inc., Seattle, WA, 98109, USA.
  • Gong J; NanoString Inc., Seattle, WA, 98109, USA.
  • Rueckert EH; NanoString Inc., Seattle, WA, 98109, USA.
  • Greenbaum BD; NanoString Inc., Seattle, WA, 98109, USA.
  • Hacohen N; NanoString Inc., Seattle, WA, 98109, USA.
  • Lagana SM; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Rivera MN; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
  • Sholl LM; The Broad Institute, Cambridge, MA, 02142, USA.
  • Stone JR; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Ting DT; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
  • Deshpande V; Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA.
Nat Commun ; 11(1): 6319, 2020 12 09.
Article in English | MEDLINE | ID: covidwho-966313
ABSTRACT
The relationship of SARS-CoV-2 pulmonary infection and severity of disease is not fully understood. Here we show analysis of autopsy specimens from 24 patients who succumbed to SARS-CoV-2 infection using a combination of different RNA and protein analytical platforms to characterize inter-patient and intra-patient heterogeneity of pulmonary virus infection. There is a spectrum of high and low virus cases associated with duration of disease. High viral cases have high activation of interferon pathway genes and a predominant M1-like macrophage infiltrate. Low viral cases are more heterogeneous likely reflecting inherent patient differences in the evolution of host response, but there is consistent indication of pulmonary epithelial cell recovery based on napsin A immunohistochemistry and RNA expression of surfactant and mucin genes. Using a digital spatial profiling platform, we find the virus corresponds to distinct spatial expression of interferon response genes demonstrating the intra-pulmonary heterogeneity of SARS-CoV-2 infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferons / Host Microbial Interactions / COVID-19 / Lung Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-20139-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferons / Host Microbial Interactions / COVID-19 / Lung Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-20139-7